Product Information
ORQUIDEA 0.35 MG TABLET is a generic product labeled by Xiromed LLC, priced at $0.0943 per EA under NDC 70700031685. Its NADAC has been published 46 times since Aug 13, 2025.
Strength
.35 mg/1
Manufacturer
Xiromed LLCNDC
70700031685
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
NORETHINDRONEApproval Type
Generic (ANDA)
FDA Application
ANDA201483On Market Since
1/29/2025
Pharmacological Classes
Price Statistics
The NADAC for ORQUIDEA 0.35 MG TABLET has been published 46 times since Aug 13, 2025, and over the history we have for it it has risen 6.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0943 per EA |
|---|---|
| All-time high | $0.0945 (Apr 15, 2026) |
| All-time low | $0.0849 (Dec 17, 2025) |
| 52-week high | $0.0945 |
| 52-week low | $0.0849 |
| Median price | $0.0913 |
| Average price | $0.0907 |
| Largest weekly change | +5.3% (Jan 21, 2026) |
| Weeks tracked | 46 |
| Tracking since | Aug 13, 2025 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ORQUIDEA 0.35 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ORQUIDEA 0.35 MG TABLET, manufactured by Xiromed LLC, is $0.0943 per EA (NDC 70700031685), effective Jun 24, 2026.
How has the price of ORQUIDEA 0.35 MG TABLET changed over time?
Over the history we have for it, the NADAC for ORQUIDEA 0.35 MG TABLET has risen 6.8%. It has been tracked across 46 weekly CMS publications since Aug 13, 2025.
What are the highest and lowest recorded NADAC prices for ORQUIDEA 0.35 MG TABLET?
Since Aug 13, 2025, the NADAC for ORQUIDEA 0.35 MG TABLET has ranged from a low of $0.0849 (Dec 17, 2025) to a high of $0.0945 (Apr 15, 2026), with a median of $0.0913 per EA.
Are there cheaper alternatives to ORQUIDEA 0.35 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as ORQUIDEA 0.35 MG TABLET, but none are currently priced below it.
Who manufactures ORQUIDEA 0.35 MG TABLET?
ORQUIDEA 0.35 MG TABLET (NDC 70700031685) is labeled by Xiromed LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification